In ambiguous immunophenotypes, indicators such as CD5, CD20, CD23, and CD200 for CLL and CD10, CD34, CD79, and CD99 for ALL, may help refine the diagnosis. The gene discussed is CD99; the disease is acute lymphoblastic leukemia.